Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Immunol ; 45(9): 2621-8, 2008 May.
Article in English | MEDLINE | ID: mdl-18280568

ABSTRACT

Intravenous immunoglobulin (IVIg) preparations are derived from pooled plasma from up to 60,000 healthy human donors and reflect the immunologic experience of the donor population. IVIg contains monomeric and dimeric IgG populations which are in a dynamic equilibrium depending on concentration, pH, temperature, donor pool size, time and stabilizers added in order to keep the portion of dimeric IgG below a certain level. In the present study, monomeric and dimeric fractions were isolated by size exclusion chromatography. The dimeric fractions, however, showed a dynamic instability and tended to dissociate. Both dimeric and monomeric IgG fractions were acid treated (pH 4) in order to dissociate the dimeric IgG. Western-blot analysis identified a sub-population of SDS resistant IgG dimers. Furthermore, the reactivities of the fractions were tested against a panel of self- and exo-antigens. There was a marked increase in activity of the dimeric compared to the monomeric IgG fraction against various intracellular self-antigens. Our data indicates that the increased reactivities of pH 4-treated fractions can mainly be attributed to dimer dissociation, as pH 4-treated monomers do not show significantly increased activities against a range of antigens.


Subject(s)
Antibody Specificity , Antigens/immunology , Autoantigens/immunology , Immunoglobulins, Intravenous/chemistry , Immunoglobulins, Intravenous/immunology , Blotting, Western , Chromatography, Gel , Dimerization , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Humans , Hydrogen-Ion Concentration , Immunoglobulins, Intravenous/isolation & purification
2.
Ann N Y Acad Sci ; 1110: 681-93, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17911483

ABSTRACT

Therapeutic intravenous immunoglobulin (IVIg) preparations contain antibodies reflecting the cumulative antigen experience of the donor population. IVIg contains variable amounts of monomeric and dimeric IgG, but there is little information available on their comparative antibody specificities. We have isolated highly purified fractions of monomeric and dimeric IgG by size-exclusion chromatography. Following treatment of all fractions at pH4, analyses by immunodot and immunocytology on human cell lines showed a preferential recognition of autoantigens in the dimeric IgG fraction. Investigation of the HEp-2 cytoplasmic proteome by 2D-PAGE, Western blot, and subsequent identification of IVIg reactive spots by mass spectrometry (LC-MS/MS) showed that IVIg recognized only a restricted set of the total proteins. Similar experiments showed that more antigens were recognized by the dimeric IgG fraction, especially when the dissociated dimer fraction was used, as compared to its monomeric counterpart. These observations are consistent with idiotype-anti-idiotype masking of auto-specific Abs in the dimeric fraction of IVIg.


Subject(s)
Autoantibodies/immunology , Immunoglobulins, Intravenous/chemistry , Immunoglobulins, Intravenous/immunology , Autoantibodies/isolation & purification , Cell Line, Tumor , Dimerization , Electrophoresis, Gel, Two-Dimensional , Humans , Immunoglobulins, Intravenous/isolation & purification , Mass Spectrometry , Protein Array Analysis
3.
Mol Immunol ; 43(7): 939-49, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16045989

ABSTRACT

Intravenous immunoglobulin (IVIG) is involved in many complex mechanisms that act in synergy including expression and function of Fc receptors, complement activation, the cytokine network, interaction with the anti-idiotypic network and modulation of B and T cell activation. To gain insight into the early effects of IVIG on this broad range of activities at the gene level we performed DNA microarray analysis. Human whole blood was incubated in vitro for 4 h followed by extraction of RNA which was hybridized to a chip containing 8793 genes. About 75 upregulated genes and 21 downregulated genes were identified using a cut off for the false discovery rate of 5%. These genes are associated with a wide range of cellular immune functions in line with the broad mechanism of action of IVIG. A striking upregulation of a series of genes coding for chemokines was measured. This finding was confirmed at the protein level as pharmacologically relevant concentrations of CXCL9 and CXCL10 were measured in serum. Interestingly, IVIG shows a partial overlap of its gene expression program with lipopolysaccharide. Our data suggests multiple hypotheses regarding the pharmacology of IVIG that must be validated by complementary studies.


Subject(s)
Blood/drug effects , Gene Expression Profiling , Gene Expression Regulation/drug effects , Immunoglobulins, Intravenous/pharmacology , Blood/immunology , Chemokine CXCL10 , Chemokine CXCL9 , Chemokines, CXC/blood , Chemokines, CXC/genetics , Genes/drug effects , Humans , Intercellular Signaling Peptides and Proteins/blood , Intercellular Signaling Peptides and Proteins/genetics , Lipopolysaccharides/pharmacology
4.
Ann N Y Acad Sci ; 1051: 582-90, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16126998

ABSTRACT

Intravenous immunoglobulin (IVIG) preparations are derived from the pooled plasma of thousands of healthy donors and contain a complex mix of antibodies. Depending on the formulation, IVIG preparations contain variable amounts of monomeric and dimeric IgG. The biological and therapeutic significance of these IVIG fractions is still ill defined. Kinetic analysis of monomeric and dimeric IgG isolated by size-exclusion chromatography revealed a stable monomeric versus an unstable dimeric IgG fraction tending to dissociation. Biochemical analysis by 2D gel electrophoresis and isotype analysis showed no significant differences between the fractions. In contrast, comparative analysis by immunodot, ELISA, FACS, and immunohistology of monomeric and dimeric IgG fractions showed a preferential reactivity of the dimeric IgG on a variety of both self-antigens and exoantigens.


Subject(s)
Immunoglobulins, Intravenous/immunology , Animals , CHO Cells , COS Cells , Chlorocebus aethiops , Cricetinae , Dimerization , Epitopes , Humans , Immunoglobulin G/chemistry , Immunoglobulin G/immunology , Immunoglobulins, Intravenous/chemistry
5.
Brain Res ; 976(2): 139-48, 2003 Jun 27.
Article in English | MEDLINE | ID: mdl-12763248

ABSTRACT

The loss of soluble brain antioxidants and protective effects of radical scavengers implicate reactive oxygen species in cortical neuronal injury caused by bacterial meningitis. However, the lack of significant oxidative damage in cortex [J. Neuropathol. Exp. Neurol. 61 (2002) 605-613] suggests that cortical neuronal injury may not be due to excessive parenchymal oxidant production. To see whether this tissue region exhibits a prooxidant state in bacterial meningitis, we examined the state of the major cortical antioxidant defenses in infant rats infected with Streptococcus pneumoniae. Adenine nucleotides were co-determined to assess possible changes in energy metabolism. Arguing against heightened parenchymal oxidant production, the high NADPH/NADP(+) ratio ( approximately 3:1) and activities of the major antioxidant defense and pentose phosphate pathway enzymes remained unchanged at the time of fulminant meningitis. In contrast, cortical ATP, ADP and total adenine nucleotides were on average decreased by approximately 25%. However, energy depletion did not lead to a significant decrease in adenylate energy charge (AEC). ATP depletion was likely a consequence of metabolic degradation, since it correlated with both the loss of total adenine nucleotides and accumulation of purine degradation products. Furthermore, the loss of ATP and decrease in AEC correlated significantly with the extent of neuronal injury. These results strongly suggest that energy depletion rather than parenchymal oxidative damage is involved in the observed cortical neuronal injury.


Subject(s)
Cerebral Cortex/enzymology , Energy Metabolism/physiology , Meningitis, Bacterial/metabolism , Oxidative Stress/physiology , Adenosine Triphosphate/metabolism , Animals , Antioxidants/pharmacology , Ascorbic Acid/pharmacology , Disease Models, Animal , Free Radicals/metabolism , NAD/metabolism , NADP/metabolism , Pentose Phosphate Pathway/physiology , Rats , Rats, Wistar , Streptococcal Infections/metabolism , Streptococcus pneumoniae
SELECTION OF CITATIONS
SEARCH DETAIL
...